1h Free Analyst Time
The transcatheter aortic valve replacement market is forecasted to grow by USD 2.40 billion during 2023-2028, accelerating at a CAGR of 6.78% during the forecast period. The report on the transcatheter aortic valve replacement market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing aging population globally, growing demand for minimally invasive procedures, and growing awareness of valvular heart diseases.
The transcatheter aortic valve replacement market is segmented as below:
By End-user
- Hospitals
- Ambulatory surgical centers
- Others
By Type
- Balloon-expanding valve
- Self expanding valve
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the transcatheter aortic valve replacement market covers the following areas:
- Transcatheter aortic valve replacement market sizing
- Transcatheter aortic valve replacement market forecast
- Transcatheter aortic valve replacement market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by End-user
7 Market Segmentation by Type
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
360 degree market analysis
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global transcatheter aortic valve replacement market: 4C Medical Technologies Inc., Abbott Laboratories, Anteris Technologies Ltd., Artivion Inc., Biosensors International Group Ltd., Boston Scientific Corp., Colibri Heart Valve LLC, Edwards Lifesciences Corp., Genesis Medtech International Pvt. Ltd., HighLife SAS, JenaValve Technology Inc., LifeNet Health Inc., LivaNova PLC, Medinol Ltd., Medtronic Plc, Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corp., Shockwave Medical Inc., Siemens AG, and Venus Medtech Hangzhou Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is growing expansion of indications for tavr procedures."
According to the report, one of the major drivers for this market is the growing aging population globally.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 4C Medical Technologies Inc.
- Abbott Laboratories
- Anteris Technologies Ltd.
- Artivion Inc.
- Biosensors International Group Ltd.
- Boston Scientific Corp.
- Colibri Heart Valve LLC
- Edwards Lifesciences Corp.
- Genesis Medtech International Pvt. Ltd.
- HighLife SAS
- JenaValve Technology Inc.
- LifeNet Health Inc.
- LivaNova Plc
- Medinol Ltd.
- Medtronic Plc
- Meril Life Sciences Pvt. Ltd.
- MicroPort Scientific Corp.
- Shockwave Medical Inc.
- Siemens AG
- Venus Medtech Hangzhou Inc.
